Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications
Background aims: Human mesenchymal stem or stromal cells (MSCs) represent a potential resource not only for regenerative medicine but also for immunomodulatory cell therapies. The application of different MSC culture protocols has significantly hampered the comparability of experimental and clinical...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 2015
|
| In: |
Cytotherapy
Year: 2015, Volume: 17, Issue: 2, Pages: 128-139 |
| ISSN: | 1477-2566 |
| DOI: | 10.1016/j.jcyt.2014.04.002 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.jcyt.2014.04.002 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1465324914005581 |
| Author Notes: | Patrick Wuchter, Karen Bieback, Hubert Schrezenmeier, Martin Bornhäuser, Lutz P. Müller, Halvard Bönig, Wolfgang Wagner, Roland Meisel, Petra Pavel, Torsten Tonn, Peter Lang, Ingo Müller, Matthias Renner, Georg Malcherek, Rainer Saffrich, Eike C. Buss, Patrick Horn, Markus Rojewski, Anita Schmitt, Anthony D. Ho, Ralf Sanzenbacher and Michael Schmitt |
Search Result 1